PlaqueTec
United Kingdom, Cambridge
About PlaqueTec
PlaqueTec is a Cambridge-based medtech company developing an intracoronary liquid biopsy approach to identify inflammatory drivers of atherosclerotic cardiovascular disease. Its proprietary device samples proteomic biomarkers directly at the site of plaque formation, feeding a clinical-and-proteomic data lake called BioCarta that powers patient endotyping, biomarker discovery and partnerships with pharmaceutical companies for cardiovascular drug development. The company is based at the Babraham Research Campus and runs the BIOPATTERN trial across a growing patient cohort.
Latest Funding
SeedAnnounced 2026-04-27
Buying Signals
Where the capital is going, and whether it's already started moving.
Spend Intent
4 signals · where the capital is going
Further development of the proprietary intracoronary liquid biopsy device and data analysis platform that samples proteomic biomarkers at the site of plaque for…
eu-startups.com
Expansion of the ongoing BIOPATTERN clinical trial across a growing patient cohort to generate proteomic data and identify therapeutic targets in coronary arter…
eu-startups.com
+2 more capital deployment signals · confidence ratings · source articles
Sign up freeIn the news
Selling to PlaqueTec? You're in the right place.
Knowing they raised is the start. The edge is what's attached to PlaqueTec.
Spend intent
Where this round will be spent.
Hiring signals
Which departments are growing.
Verified contacts
Who actually decides.
No credit card. Five minutes, no approvals.
Ask AI
What is the unique value proposition of PlaqueTec, and who are their main competitors?
Sign up free to ask AI about PlaqueTec
Our AI has read their website, news, and funding history. 25 credits included with every free account.
Sign up free: 25 credits includedAuto-matched to your ICP
Every company, scored against your profile. Automatically.
Industry
High
Size
Mid
Stage
High
Match score blends industry, company size, growth stage, tech stack, and geography. The moment you set your ICP, every company in our database gets scored.
Investors
Tech Stack
Wix
React
Lodash
Contacts
Sarah M.
Head of Sales
Sample preview. Sign up free to see real contacts
Key Highlights
AI InsightsRound was oversubscribed and exceeded the company target, funded entirely by PlaqueTec existing investor base with no new investors disclosed.
AI reads their website, press releases, and funding context to surface what makes them unique - so you tailor your pitch before the first call.
Try it free →Generates a personalized cold email based on their funding round, capital deployment signals, and company context. Ready to send in under 10 seconds.
Try it free →Short, personalized connection request crafted around their recent funding and what your product can help them achieve with it.
Try it free →Maps their competitive landscape with AI - invaluable context before your first call and for positioning your pitch against their alternatives.
Try it free →Extracts capital deployment signals from their funding news - reach out knowing exactly where they're investing and why your product fits.
Try it free →Similar Companies
Discover companies similar to PlaqueTec
Selling to PlaqueTec? You're in the right place.
Knowing they raised is the start. Our difference is what comes attached to PlaqueTec.
Spend Intent
Where this round will be spent.
Hiring Signals
Which departments are growing.
Verified Contacts
Who actually decides.
No credit card. Five minutes, no approvals.
Free weekly newsletter on startup funding.
20 rounds, ranked by amount. Industry and stage breakdowns. A short market note. One email, free, no noise. 2,000+ subscribers.
No spam, ever. Unsubscribe with one click.